Tag: #Global Trends

A therapeutics company has announced a funding agreement worth $275 million with a financial fund specializing in pharmaceutical royalties. The... Read more

A therapeutics company has announced positive topline results from its pivotal Phase 3 HOPE-3 clinical trial, evaluating the efficacy of... Read more

The European Commission has granted authorization for nipocalimab, an immunoglobulin G (IgG) receptor antagonist developed by Johnson & Johnson, for... Read more

Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has announced the retirement of its Managing Director, Thomas Otto,... Read more

A new follow-up study, published in the journal Cell, adds evidence that the shingles vaccine, a two-dose shot recommended for... Read more

Bristol Myers Squibb (BMS) has announced an extension and increased enrollment for its late-stage clinical trial, “ADEPT-2,” of the drug... Read more

The U.S. Food and Drug Administration (FDA) is once again searching for a leader for its Center for Drug Evaluation... Read more

Excelsior Sciences, an artificial intelligence (AI) chemistry firm, is gaining ground on its mission to hasten the discovery and production... Read more

The Johnson & Johnson (J&J) corporation has teamed up with the acclaimed actress Naomi Watts in a communication campaign to... Read more